Class II
Terminated
Bisacodyl Suppositories, Brite Stock, Reese.
Why: cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
- Company
- Torrent Pharma Inc
Levittown, PA, United States - Reported
- Jun 19, 2019
- Recall started
- May 21, 2019
- Ended
- Oct 6, 2020
- Where sold
- Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.
- Amount
- N/A
- Full product description
- Bisacodyl Suppositories, Brite Stock, Reese.
- Lots / codes affected
- Lot #s: 17J003, Exp. 09/2019; 18A026, Exp. 01/2020; 18E031, Exp. 05/2020.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.